Jonathan McNeill, Chief Business Officer: Dyne Therapeutics DYN Sell · Filed 24/01/26

Trade details

Type: Insider sale
Amount: $486,035.44
Shares · price: 19,822 sh · $24.52 a share
Held after: 143,796 sh
Stock: Dyne Therapeutics DYN
Person: Jonathan McNeillChief Business Officer
Trade date: 24/01/26
Filed: 24/01/26
Days to filing: 0 days

Sold 12.1% of holdings

Share of holding sold: 12.1%

Dyne Therapeutics trades, last 26 weeks

What else happened in Dyne Therapeutics around then

Filed or reported within 30 days of the trade day · 23/12/27~24/02/25

Jonathan McNeill's recent trades

Jonathan McNeillPresident and COO
Planned sale10b5-1 planCrescent Biopharma
Planned sale10b5-1 plan
Crescent Biopharma
CBIO
$75.8K
4,415 sh
$75.8K
Filed 09/17
Traded 09/18
Jonathan McNeillPresident and COO
Planned sale10b5-1 planCrescent Biopharma
Planned sale10b5-1 plan
Crescent Biopharma
CBIO
$15.1K
804 sh
$15.1K
Filed 09/16
Traded 09/16
Jonathan McNeillPresident and COO
Sell10b5-1 planCrescent Biopharma
Sell10b5-1 plan
Crescent Biopharma
CBIO
$369.7K
20,549 sh
$369.7K
Filed 06/23
Traded 06/22
Jonathan McNeillChief Business Officer
Sell10b5-1 planDyne Therapeutics
Sell10b5-1 plan
Dyne Therapeutics
DYN
$108K
2,400 sh
$108K
Filed 24/08/20
Traded 24/08/19
Jonathan McNeillChief Business Officer
Sell10b5-1 planDyne Therapeutics
Sell10b5-1 plan
Dyne Therapeutics
DYN
$14K
305 sh
$14K
Filed 24/08/20
Traded 24/08/19

Jonathan McNeill, Chief Officer — sold $486K of Dyne Therapeutics DYN · 12.1% of holdings · 10b5-1 plan | Whalegun